Clinical Trial Update: Leaders Free Japan [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Leaders Free Japan sponsored by Biosensors Europe SA investigating coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Biosensors Europe SA | Conditions: Coronary Disease | Phase 3 | Status: UNKNOWN